Study of an experimental anemia treatment for chemotherapy patients
Part of Blood & lymphatic clinical trials.
This study tests a new medication (SAL-0951) for treating low red blood cell counts (anemia) caused by chemotherapy in people with certain types of cancer that are not curable. It may help improve energy and reduce the need for blood transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must weigh at least 40 kg (about 88 pounds).
- You must have a type of cancer (not leukemia or myeloma) that is not curable, and you must be scheduled to receive chemotherapy for at least 6 more weeks.
- Your hemoglobin level must be 100 g/L or lower, and it must have dropped by at least 10 g/L after starting chemotherapy.
- Your iron levels (ferritin and transferrin saturation) must meet certain minimums.
- You must be in fairly good health (able to do light activities) and have a life expectancy of at least 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving iron (iron sucrose) can reduce anemia during chemotherapy before curative surgery. It may help you feel better and have smoother treatment by improving low blood counts caused by iron deficiency.
This Phase 1 trial tests how safe APG-5918 is, how the body processes it, and looks for early signs it may help people with certain types of anemia. It may include healthy volunteers and people with anemia, but the study is very selective to protect participants.
This trial tests an experimental drug, HS-20106, to see if it can improve low red blood cell counts (anemia) for people with a certain type of bone marrow disorder called myelodysplastic syndromes (MDS), which is not high risk. It might be an option if you have not received certain prior treatments.
This early-stage study tests a new experimental drug called CTX001 in healthy volunteers to check if it is safe and well-tolerated. Researchers will also measure how your body processes the drug and how it affects certain blood markers.
This early trial studies whether an engineered (lab-made) red blood cell treatment is safe and tolerable, and whether it may show early anti-cancer activity. It may help people with advanced cancers whose disease has not responded well to standard options.
This trial tests a new drug, SSS06, for treating anemia caused by chemotherapy in people with certain cancers. The goal is to see if it can help raise red blood cell levels safely.
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.